FindTrial
Sign In

A case records based study for closure or medication therapy for prevetion and treatment of cryptogenic stroke and migraine in patient with Patent Foramen Ovale

A case records based study for closure or medication therapy for prevetion and treatment of cryptogenic stroke and migraine in patient with Patent Foramen Ovale

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020983
Enrollment
Unknown
Registered
2019-01-23
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patent foramen ovale,cryptogenic stroke,migraine

Interventions

Drug therapy group:Oral medicine
PFO closure group:PFO closure

Sponsors

Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients with cryptogenic stroke within 6 months/migraine diagnosed in neurology and cardiology; 2. patients at least 14 years old; 3. Fully understand and volunteer to participate in the study.

Exclusion criteria

Exclusion criteria: 1. hemorrhagic stroke; 2. pulmonary hypertension; 3. right ventricular cardiomyopathy; 4. pulmonary valve stenosis, pulmonary artery stenosis or right ventricular outflow tract stenosis; 5. moderate to severe tricuspid regurgitation caused by various causes.

Design outcomes

Primary

MeasureTime frame
PFO;—

Countries

China

Contacts

Public ContactYuanpeng Xia

Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

xiayuanpeng@hust.edu.cn+86 13618606828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026